会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • SYNTHESIS Of DIETHYLPHOSPHONATE
    • 二乙基磷酸酯的合成
    • US20100137597A1
    • 2010-06-03
    • US12701174
    • 2010-02-05
    • Kelvin H. YongIlia A. ZavialovJianguo YinXiaoyong FuTiruvettipuram K. Thiruvengadam
    • Kelvin H. YongIlia A. ZavialovJianguo YinXiaoyong FuTiruvettipuram K. Thiruvengadam
    • C07F9/40
    • C07D405/06C07F9/58
    • This application discloses a novel process for the preparation of phosphonate esters useful as intermediates in the preparation of himbacine analogs, themselves useful as thrombin receptor antagonists. The chemistry taught herein can be exemplified by the following scheme: wherein R9 is selected from alkyl, aryl heteroaryl and arylalkyl groups having 1 to 10 carbon atoms, and R11 is selected independently for each occurrence from alkyl, aryl heteroaryl and arylalkyl groups having 1 to 10 carbon atoms and hydrogen, X2 is Cl, Br, or I; X3 is selected from Cl and Br; and PdLn is a supported palladium metal catalyst or a soluble heterogeneous palladium catalyst. The L-derivatizing reagent is a moiety which converts the alcohol functional group of compound 137D to any leaving group which can be displaced by a triorgano-phosphite phosphonating agent.
    • 本申请公开了一种制备膦酸酯的新方法,其可用作制备作为凝血酶受体拮抗剂的替卡宾类似物的中间体。 本文教导的化学实例可以通过以下方案来举例说明:其中R9选自具有1-10个碳原子的烷基,芳基杂芳基和芳基烷基,R11各自独立地选自烷基,芳基杂芳基和具有1至 10个碳原子和氢,X2是Cl,Br或I; X3选自Cl和Br; PdLn是负载型钯金属催化剂或可溶性多相钯催化剂。 L-衍生试剂是将化合物137D的醇官能团转化成可被三有机 - 亚磷酸酯膦酸酯取代的任何离去基团的部分。
    • 10. 发明授权
    • Process for preparing acetonides
    • 丙酮化合物的制备方法
    • US06482952B2
    • 2002-11-19
    • US09883417
    • 2001-06-18
    • Steven J. CianciosiGregory L. TewaltEric T. PiskIlia A. ZavialovGlenn A. Hulvey
    • Steven J. CianciosiGregory L. TewaltEric T. PiskIlia A. ZavialovGlenn A. Hulvey
    • C07D26352
    • C07D263/52
    • Acetonides are obtained in a one-step reaction of a carboxylic acid halide, a 1,2-aminoalcohol, and 2-alkoxypropene or 2,2-dialkoxypropane in an ether solvent and in the presence of an inorganic base. Acetonides are also obtained in a two-step reaction scheme in which an acid halide and 1,2-aminoalcohol are reacted in an ether solvent in the presence of LiOH to form a hydroxyamide, which is then reacted with 2-alkoxypropene or 2,2-dialkoxypropane in the presence of acid to form the acetonide. The acetonides resulting from the one-step and two-step protocols can be further reacted with an allylating agent such as an allyl halide in the presence of a strong base to provide the corresponding allyl acetonide. The acetonides and allyl acetonides can serve as intermediates in the production of certain HIV protease inhibitors which are useful for treating HIV infection and AIDS.
    • 在醚溶剂中和无机碱的存在下,在羧酸卤化物,1,2-氨基醇和2-烷氧基丙烯或2,2-二烷氧基丙烷的一步反应中获得乙氧基化物。 乙酸酯也是以两步反应方案获得的,其中酰卤和1,2-氨基醇在醚溶剂中在LiOH存在下反应形成羟基酰胺,然后与2-烷氧基丙烯或2,2 二烷氧基丙烷在酸存在下形成丙酮化合物。 由一步法和两步法得到的丙酮化合物可以在强碱存在下与烯丙基化剂如烯丙基化物进一步反应,得到相应的烯丙基丙酮化合物。 丙酮化合物和烯丙基丙酮化物可用作生产某些可用于治疗艾滋病毒和艾滋病的HIV蛋白酶抑制剂的中间体。